Showing results (191-200 of 198) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Molecules (Basel, Switzerland)|November 26, 2022
Grafting of Anionic Decahydro-Closo-Decaborate Clusters on Keggin and Dawson-Type Polyoxometalates: Syntheses, Studies in Solution, DFT Calculations and Electrochemical PropertiesManal Diab, Ana Mateo, Joumada El Cheikh, et al.Chembiochem : a European Journal of Chemical Biology|January 5, 2021
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine MethyltransferaseVladimir O Talibov, Edoardo Fabini, Edward A FitzGerald, et al.Communications Chemistry|August 1, 2025
A bottom-up approach to find lead compounds in expansive chemical spacesÁlvaro Serrano-Morrás, Andrea Bertran-Mostazo, Marina Miñarro-Lleonar, et al.Molecular Cancer Therapeutics|April 14, 2007
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analoguesSwee Y Sharp, Chrisostomos Prodromou, Kathy Boxall, et al.Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.Cancer Research|April 17, 2008
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasisSuzanne A Eccles, Andy Massey, Florence I Raynaud, et al.Journal of Medicinal Chemistry|November 21, 2007
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancerPaul A Brough, Wynne Aherne, Xavier Barril, et al.Breast Cancer Research : BCR|June 3, 2014
VAV3 mediates resistance to breast cancer endocrine therapyHelena Aguilar, Ander Urruticoechea, Pasi Halonen, et al.Pageof 20